Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment.
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
Market Analysis and Insights: Global Adrenocortical Carcinoma Treatment Market
The global Adrenocortical Carcinoma Treatment market size is projected to reach US$ 545.6 million by 2026, from US$ 537 million in 2020, at a CAGR of 1.5%% during 2021-2026.
Global Adrenocortical Carcinoma Treatment Scope and Market Size
Adrenocortical Carcinoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
...
Adrenocortical Carcinoma Treatment Breakdown Data by Type
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma
Adrenocortical Carcinoma Treatment Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
Market Analysis and Insights: Global Adrenocortical Carcinoma Treatment Market
The global Adrenocortical Carcinoma Treatment market size is projected to reach US$ 545.6 million by 2026, from US$ 537 million in 2020, at a CAGR of 1.5%% during 2021-2026.
Global Adrenocortical Carcinoma Treatment Scope and Market Size
Adrenocortical Carcinoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
...
Adrenocortical Carcinoma Treatment Breakdown Data by Type
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma
Adrenocortical Carcinoma Treatment Breakdown Data by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Localized Adrenocortical Carcinoma
1.4.3 Metastatic Adrenocortical Carcinoma
1.5 Market by Application
1.5.1 Global Adrenocortical Carcinoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Adrenocortical Carcinoma Treatment Market Perspective (2015-2026)
2.2 Global Adrenocortical Carcinoma Treatment Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adrenocortical Carcinoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Adrenocortical Carcinoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Adrenocortical Carcinoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adrenocortical Carcinoma Treatment Players by Market Size
3.1.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Adrenocortical Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio
3.2.1 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Treatment Revenue in 2019
3.3 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
3.4 Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
3.5 Date of Enter into Adrenocortical Carcinoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
5.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
6.2 Adrenocortical Carcinoma Treatment Key Players in North America (2019-2020)
6.3 North America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
6.4 North America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adrenocortical Carcinoma Treatment Market Size (2015-2020)
7.2 Adrenocortical Carcinoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
7.4 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Adrenocortical Carcinoma Treatment Market Size (2015-2020)
8.2 Adrenocortical Carcinoma Treatment Key Players in China (2019-2020)
8.3 China Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
8.4 China Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adrenocortical Carcinoma Treatment Market Size (2015-2020)
9.2 Adrenocortical Carcinoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
9.4 Japan Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Adrenocortical Carcinoma Treatment Market Size (2015-2020)
10.2 Adrenocortical Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Adrenocortical Carcinoma Treatment Market Size (2015-2020)
11.2 Adrenocortical Carcinoma Treatment Key Players in India (2019-2020)
11.3 India Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
11.4 India Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
12.2 Adrenocortical Carcinoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 ArQule
13.1.1 ArQule Company Details
13.1.2 ArQule Business Overview
13.1.3 ArQule Adrenocortical Carcinoma Treatment Introduction
13.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020))
13.1.5 ArQule Recent Development
13.2 EnGeneIC
13.2.1 EnGeneIC Company Details
13.2.2 EnGeneIC Business Overview
13.2.3 EnGeneIC Adrenocortical Carcinoma Treatment Introduction
13.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.2.5 EnGeneIC Recent Development
13.3 Exelixis
13.3.1 Exelixis Company Details
13.3.2 Exelixis Business Overview
13.3.3 Exelixis Adrenocortical Carcinoma Treatment Introduction
13.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.3.5 Exelixis Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Adrenocortical Carcinoma Treatment Introduction
13.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Millendo Therapeutics
13.5.1 Millendo Therapeutics Company Details
13.5.2 Millendo Therapeutics Business Overview
13.5.3 Millendo Therapeutics Adrenocortical Carcinoma Treatment Introduction
13.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.5.5 Millendo Therapeutics Recent Development
13.6 Orphagen Pharmaceuticals
13.6.1 Orphagen Pharmaceuticals Company Details
13.6.2 Orphagen Pharmaceuticals Business Overview
13.6.3 Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Introduction
13.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.6.5 Orphagen Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Localized Adrenocortical Carcinoma
1.4.3 Metastatic Adrenocortical Carcinoma
1.5 Market by Application
1.5.1 Global Adrenocortical Carcinoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Adrenocortical Carcinoma Treatment Market Perspective (2015-2026)
2.2 Global Adrenocortical Carcinoma Treatment Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adrenocortical Carcinoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Adrenocortical Carcinoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Adrenocortical Carcinoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adrenocortical Carcinoma Treatment Players by Market Size
3.1.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Adrenocortical Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio
3.2.1 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Treatment Revenue in 2019
3.3 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
3.4 Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
3.5 Date of Enter into Adrenocortical Carcinoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
5.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
6.2 Adrenocortical Carcinoma Treatment Key Players in North America (2019-2020)
6.3 North America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
6.4 North America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adrenocortical Carcinoma Treatment Market Size (2015-2020)
7.2 Adrenocortical Carcinoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
7.4 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Adrenocortical Carcinoma Treatment Market Size (2015-2020)
8.2 Adrenocortical Carcinoma Treatment Key Players in China (2019-2020)
8.3 China Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
8.4 China Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adrenocortical Carcinoma Treatment Market Size (2015-2020)
9.2 Adrenocortical Carcinoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
9.4 Japan Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Adrenocortical Carcinoma Treatment Market Size (2015-2020)
10.2 Adrenocortical Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Adrenocortical Carcinoma Treatment Market Size (2015-2020)
11.2 Adrenocortical Carcinoma Treatment Key Players in India (2019-2020)
11.3 India Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
11.4 India Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
12.2 Adrenocortical Carcinoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 ArQule
13.1.1 ArQule Company Details
13.1.2 ArQule Business Overview
13.1.3 ArQule Adrenocortical Carcinoma Treatment Introduction
13.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020))
13.1.5 ArQule Recent Development
13.2 EnGeneIC
13.2.1 EnGeneIC Company Details
13.2.2 EnGeneIC Business Overview
13.2.3 EnGeneIC Adrenocortical Carcinoma Treatment Introduction
13.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.2.5 EnGeneIC Recent Development
13.3 Exelixis
13.3.1 Exelixis Company Details
13.3.2 Exelixis Business Overview
13.3.3 Exelixis Adrenocortical Carcinoma Treatment Introduction
13.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.3.5 Exelixis Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Adrenocortical Carcinoma Treatment Introduction
13.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Millendo Therapeutics
13.5.1 Millendo Therapeutics Company Details
13.5.2 Millendo Therapeutics Business Overview
13.5.3 Millendo Therapeutics Adrenocortical Carcinoma Treatment Introduction
13.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.5.5 Millendo Therapeutics Recent Development
13.6 Orphagen Pharmaceuticals
13.6.1 Orphagen Pharmaceuticals Company Details
13.6.2 Orphagen Pharmaceuticals Business Overview
13.6.3 Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Introduction
13.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.6.5 Orphagen Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
